Research coauthored by RTI Health Solutions researchers is being presented at ASH 2019.
Overall survival, adverse events, and economic burden in Medicare patients with chronic lymphocytic leukemia receiving cancer-directed therapy. Goyal RK, Nagar SP, Kabadi SM, Davis KL, Le H, Kaye JA. Poster
James Kaye, MD, DrPH, Senior Director, Epidemiology, RTI Health Solutions will be presenting this research.
Monday, December 9, 2019: 3:30 PM
Overall survival, adverse events, and economic burden in Medicare-insured patients with mantle cell lymphoma receiving cancer-directed therapy. Kabadi S, Goyal RK, Nagar SP, Davis KL, Le H, Du XL, Jain P, Wang M, Romaguera JE, Kaye JA. Poster
Saturday, December 7, 2019: 8:00 AM
Click here if you'd like to reach out to James Kaye, who will be attending the conference.